These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7483800)

  • 1. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.
    Miller E; Hill A; Morgan-Capner P; Forsey T; Rush M
    Vaccine; 1995 Jun; 13(9):799-802. PubMed ID: 7483800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I; Peltola H; Leinikki P; Valle M
    Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children.
    Usonis V; Bakasenas V; Chitour K; Clemens R
    Infection; 1998; 26(4):222-6. PubMed ID: 9717679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
    Crovari P; Gabutti G; Giammanco G; Dentico P; Moiraghi AR; Ponzio F; Soncini R
    Vaccine; 2000 Jun; 18(25):2796-803. PubMed ID: 10812221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR.
    Mitchell LA; Tingle AJ; Décarie D; Lajeunesse C
    Can J Public Health; 1998; 89(5):325-8. PubMed ID: 9813922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE
    J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
    Khalil M; Poltera AA; al-Howasi M; Herzog C; Gerike E; Wegmüller B; Glück R
    Trans R Soc Trop Med Hyg; 1999; 93(2):214-9. PubMed ID: 10450452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V; Bakasenas V; Kaufhold A; Chitour K; Clemens R
    Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.
    Boulianne N; De Serres G; Ratnam S; Ward BJ; Joly JR; Duval B
    Vaccine; 1995 Nov; 13(16):1611-6. PubMed ID: 8578850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G; Peña B; Marimón JM; Pérez-Trallero E
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months.
    Forleo-Neto E; Carvalho ES; Fuentes IC; Precivale MS; Forleo LH; Farhat CK
    Vaccine; 1997 Dec; 15(17-18):1898-901. PubMed ID: 9413099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age.
    Klinge J; Lugauer S; Korn K; Heininger U; Stehr K
    Vaccine; 2000 Jul; 18(27):3134-40. PubMed ID: 10856793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immunogenicity of simultaneous and nonsimultaneous vaccination with MMR and JE vaccine among 15-month-old children.
    Tseng CY; Hwang KP; Lin KH; Chen HY; Lu CC; Chiang CH
    Acta Paediatr Taiwan; 1999; 40(3):161-5. PubMed ID: 10910607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
    Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.